Research records indexed for Ibutamoren
This page carries 12 of the 30 records that the literature query returned for Ibutamoren, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 18 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Ibutamoren.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Knowing the minimal detectable dose can facilitate the interpretation of a hair test result: II. Case example with ibutamoren (MK-677), a growth hormone secretagogue pmid:40882886 | 2026 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Humans" with no interventional publication type. subject headings: Hair; Substance Abuse Detection; Doping In Sports; Limit Of Detection. |
| Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices pmid:42328738 | 2026 | Journal Article | other | Not stated | Indexed as journal article. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Peptides; Doping In Sports; Limit Of Detection; Dried Blood Spot Testing; Liquid Chromatography-Mass Spectrometry. |
| Investigating the P53-dependent anti-cancer effect of ibutamoren in human cancer cell lines pmid:39668330 | 2025 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Humans" with no interventional publication type. subject headings: Cell Line, Tumor; Neoplasms; Antineoplastic Agents; Inhibitory Concentration 50; Apoptosis. |
| SARMs, Metabolic Modulators and Growth Hormone Secretagogues in Suspected Illegal Medicines, Bought as Sport Performance Enhancers: A Retro- and Prospective Study Within the GEON pmid:40551438 | 2025 | Journal Article | other | Not stated | Indexed as journal article. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Receptors, Androgen; Anabolic Agents; Prospective Studies; Substance Abuse Detection; Doping In Sports. |
| Design, Biological Characterization, and Discovery of Capromorelin Derivatives as Oral Growth Hormone Secretagogue Receptor Type 1a Agonist for the Treatment of Growth Hormone Deficiency pmid:40091212 | 2025 | Journal Article | rodent | Not stated | Indexed as journal article. compound named in the abstract, not the title. study model from MeSH "Rats". subject headings: Dogs; Rats, Sprague-Dawley; Growth Hormone; Human Growth Hormone; Administration, Oral. |
| New directions in growth hormone treatment in children pmid:41693185 | 2025 | editorial, Review | other | Not stated | Indexed as editorial, review. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Growth Disorders; Human Growth Hormone. |
| Characterization of growth hormone secretagogue small molecule ibutamoren (MK-0677) and its possible metabolites in thoroughbred horses for doping control pmid:35716382 | 2022 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Animals" with no rodent species heading. subject headings: Horses; Indoles; Spiro Compounds; Growth Hormone; Substance Abuse Detection. |
| Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren pmid:34737341 | 2021 | Research Support, Non-U.S. Gov't, research-article | other | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Humans" with no interventional publication type. subject headings: Signal Transduction; Ghrelin; Receptors, Ghrelin. |
| Characterization of equine liver microsome-generated metabolites of growth hormone secretagogue small molecule ibutamoren pmid:34542924 | 2021 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Animals" with no rodent species heading. subject headings: Microsomes, Liver; Horses; Indoles; Spiro Compounds; Chromatography, High Pressure Liquid. |
| Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles pmid:31964466 | 2020 | research-article | other | Not stated | Indexed as research-article. study model from MeSH "Humans" with no interventional publication type. subject headings: Imidazoles; Indoles; Viral Proteins; RNA; Antiviral Agents. |
| MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study pmid:21067829 | 2011 | Clinical Trial, Phase II, Comparative Study | human trial | Not stated | Indexed as clinical trial, phase ii, comparative study. study model from MeSH "Humans" with publication type "clinical trial, phase ii". subject headings: Lower Extremity; Hip Fractures; Indoles; Spiro Compounds; Range Of Motion, Articular. |
| Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children pmid:11452249 | 2001 | Clinical Trial, Research Support, Non-U.S. Gov't | human trial | Not stated | Indexed as clinical trial, research support, non-u.s. gov't. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Metabolism, Inborn Errors; Indoles; Spiro Compounds; Growth Hormone; Insulin-Like Growth Factor I. |
Where this page sits
Compound page: Ibutamoren. Class: Growth hormone secretagogues.
Retrieved 2026-10-10.
Sources
- PubChem Compound Summary for CID 178024, Ibutamoren. PubChem, National Library of Medicine (2026). pubchem:178024
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:ibutamoren
- Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children. Clin Pharmacol Ther (2001). pmid:11452249
- Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren. Nat Commun (2021). pmid:34737341
- MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study. Arch Gerontol Geriatr (2011). pmid:21067829
- Characterization of growth hormone secretagogue small molecule ibutamoren (MK-0677) and its possible metabolites in thoroughbred horses for doping control. Rapid Commun Mass Spectrom (2022). pmid:35716382
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.